Has Shelby Gino received payments from drug or device companies?

Yes. Drug and device makers reported $2,493 in general payments to Shelby Gino across 113 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Shelby Gino did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Shelby Gino come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Shelby Gino

Nurse Practitioner · Roseville, MINPI 1730924598

Payments from drug & device makers

$2,493in general payments, 2019–2025

Across 113 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Genentech USA, Inc.$234
Sanofi$213
Incyte Corporation$190
Novartis$172
Regeneron Healthcare Solutions, Inc.$116
Daiichi Sankyo Inc.$106
plus $1K from 32 others

What the payments were for

Food & beverage$2,39896%
Education$964%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Genentech USA, Inc.	16	$234
Sanofi	4	$213
Incyte Corporation	6	$190
Novartis	8	$172
Regeneron Healthcare Solutions, Inc.	4	$116
Daiichi Sankyo Inc.	5	$106
AstraZeneca	4	$103
Eisai Inc.	4	$94
Merck	4	$84
Takeda Pharmaceuticals U.S.A., Inc.	4	$80
Tersera Therapeutics LLC	3	$79
Sobi, Inc	4	$78
Astellas Pharma US Inc	4	$66
Bristol Myers Squibb	3	$60
Johnson & Johnson	3	$58
Servier Pharmaceuticals LLC	3	$57
Exelixis Inc.	3	$57
Caris MPI, Inc.	2	$54
Lilly USA, LLC	3	$53
E.r. Squibb & Sons, L.L.C.	2	$52
EMD Serono, Inc.	2	$50
Stemline Therapeutics Inc.	2	$46
Rigel Pharmaceuticals, Inc.	2	$44
Geron Corporation	2	$36
Deciphera Pharmaceuticals Inc.	2	$31
AVEO Pharmaceuticals, Inc.	2	$30
Beone Medicines USA, Inc.	1	$28
Pfizer	1	$26
Pharmaessentia USA Corporation	1	$25
Karyopharm Therapeutics Inc.	1	$24
Fresenius Kabi USA, LLC	1	$22
Tempus AI, Inc	1	$21
GSK	1	$21
Beigene USA, Inc.	1	$19
Acrotech Biopharma Inc.	1	$18
Gilead	1	$17
Myriad Genetic Laboratories, Inc.	1	$16
Azurity Pharmaceuticals, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SARCLISA$125

How this compares

$2,493 in reported general payments places this provider in the 90th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prochlorperazine Maleate	32	$388
Lidocaine-PrilocaineLidocaine/Prilocaine	14	$170
Ondansetron Hcl	20	$82

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Roseville

Davida KrugerDetroit$1.8M
Kari HillSpring Lake$426K
Kyle FarrPlymouth$243K
Linda SpencerTroy$217K
Ellen DillardDetroit$168K
Golbon AghamohammadiDetroit$157K
Abubakir BabanDearborn$143K
Elizabeth KirshnerAnn Arbor$119K
Lisa Astalos ChismWoodhaven$103K
Martha GoetzPetoskey$101K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →